Dear Sir, Please find the attachment. Regards, For MRC Agrotech Limited Compliance Officer/ Authorised Signatory
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.1 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
MRC Agrotech has filed a corrigendum to its June 28, 2025 EGM notice, revising the use of proceeds from its preferential equity issue. Originally earmarked for repayment of borrowings, the ₹428.59 lakh cash component (21,97,910 shares at ₹19.50 each) will now fund working capital (₹313.30 lakh), R&D, bio-formulation, nutraceuticals and soil-health product expansion (₹100 lakh), and general corporate purposes (₹15.29 lakh). The larger 86,42,097-share tranche (₹16.85 crore) is a non-cash swap for acquiring 100% of MARSAPI Lifesciences Pvt Ltd. The company is also increasing its authorized share capital from ₹20.5 crore to ₹35.5 crore. Issue price, number of shares, and allottees remain unchanged.
This is a procedural correction, not a change in the deal structure. The pivot away from debt repayment toward growth spending (working capital and R&D) suggests management sees adequate liquidity and prefers funding expansion. Dilution from the cash + swap issue is unchanged; existing shareholders may see modest pressure but also benefit if MARSAPI integration and product expansion pay off.